TEKLA CAPITAL MANAGEMENT LLC VYNE Therapeutics Inc. Transaction History

TEKLA CAPITAL MANAGEMENT LLC portfolio value:

$30,000
portfolio value

TEKLA CAPITAL MANAGEMENT LLC quarter portfolio value change:

-42.63%
quarter

VYNE Therapeutics Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -23K $0.22 135.39K
Q2 2022 share 0.00% 0 shares -35K $0.39 135.39K
Q1 2022 share 0.00% 0 shares -50K $0.65 135.39K
Q4 2021 share 0.00% 0 shares -50K $1.08 135.39K
Q3 2021 share 0.00% 0 shares -287K $1.39 135.39K
Q2 2021 share 0.00% 0 shares -452K $3.51 135.39K
Q1 2021 share Increase 0.00% 135.39K shares 927K $6.85 135.39K